[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hypoparathyroidism":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":60,"states":61},"Hypoparathyroidism",8,7,[8,16,23,29,35,41,47,53],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07081997","A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg\u002FDay in Adult Participants With Hypoparathyroidism",[12],"Phase 3","RECRUITING","2026-08-26T02:17:18.747857Z","2026-05-05T02:43:27.962795Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06961071","Parathyroid Allotransplant for Treatment of Hypoparathyroidism",[20],"Phase 1\u002FPhase 2","2026-08-26T02:17:28.381459Z","2026-04-29T02:57:57.075251Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07699471","A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism",[12],"2026-08-26T02:19:12.219640Z","2026-07-19T19:36:05.078444Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07345494","A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding",[],"2026-08-26T02:15:45.413021Z","2026-05-13T02:55:06.688267Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07264634","A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)",[],"2026-08-26T02:15:23.202838Z","2026-05-13T02:55:06.682422Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT05793853","Hypoparathyroidism Natural History Study",[],"2026-08-26T02:18:46.948970Z","2026-05-13T02:55:06.377318Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07083557","Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)",[],"2026-08-26T02:16:46.147215Z","2026-05-13T02:55:06.654220Z",{"nct_id":54,"title":55,"phases":56,"status":57,"updated_at":58,"content_modified":59},"NCT05114980","Parathyroid Allotransplantation in Medically Refractory Hypoparathyroidism",[],"NOT_YET_RECRUITING","2026-08-03T02:56:50.780912Z","2026-05-05T02:43:28.221979Z",[],[]]